$4.365
-0.035[-0.80%]
At close: Apr 25
$4.01
-0.3550[-8.13%]
After Hours: 8:49AM EDT
Marker Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Marker Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/13/2024 | PM | MRKR | Q1 | -$0.57 | — | — | — | $4.73M | — | — | — | Get Alert |
05/07/2024 | PM | MRKR | Q4 | -$0.45 | — | — | — | $3.31M | — | — | — | Get Alert |
11/09/2023 | PM | MRKR | Q3 | -$0.80 | — | -$0.34 | — | $3.95M | — | $257.61K | — | Get Alert |
08/14/2023 | PM | MRKR | Q2 | -$1.10 | — | -$0.47 | — | $790.51K | — | $762.66K | — | Get Alert |
05/15/2023 | PM | MRKR | Q1 | -$1.20 | -$0.80 | -$0.57 | 28.75% | $964.32K | — | $4.73M | — | Get Alert |
03/22/2023 | PM | MRKR | Q4 | -$1.00 | -$1.60 | -$0.45 | 71.88% | $0.00 | — | $3.31M | — | Get Alert |
11/10/2022 | PM | MRKR | Q3 | -$1.50 | -$1.20 | -$0.80 | 33.33% | $0.00 | $270.00K | $3.95M | 1362.96% | Get Alert |
08/11/2022 | PM | MRKR | Q2 | -$1.30 | -$1.30 | -$1.10 | 15.38% | $0.00 | $670.00K | $790.51K | 17.99% | Get Alert |
05/13/2022 | PM | MRKR | Q1 | -$1.60 | — | -$1.20 | — | $0.00 | — | $964.32K | — | Get Alert |
03/17/2022 | PM | MRKR | Q4 | -$1.80 | -$1.30 | -$1.20 | 7.69% | $0.00 | — | $0.00 | — | Get Alert |
11/10/2021 | PM | MRKR | Q3 | -$1.60 | -$1.30 | -$1.20 | 7.69% | $0.00 | — | $0.00 | — | Get Alert |
08/10/2021 | PM | MRKR | Q2 | -$1.40 | -$1.20 | -$1.30 | -8.33% | $466.79K | — | $0.00 | — | Get Alert |
05/12/2021 | PM | MRKR | Q1 | -$1.40 | -$1.40 | -$1.60 | -14.29% | $0.00 | — | $0.00 | — | Get Alert |
03/09/2021 | PM | MRKR | Q4 | -$1.10 | — | -$1.80 | — | $213.19K | — | $0.00 | — | Get Alert |
11/09/2020 | PM | MRKR | Q3 | -$1.20 | -$1.40 | -$1.60 | -14.29% | $0.00 | — | $0.00 | — | Get Alert |
08/10/2020 | PM | MRKR | Q2 | -$1.20 | — | -$1.40 | — | — | — | $466.79K | — | Get Alert |
05/11/2020 | PM | MRKR | Q1 | — | -$1.10 | -$1.40 | -27.27% | — | — | $0.00 | — | Get Alert |
03/12/2020 | PM | MRKR | Q4 | — | — | -$1.10 | — | — | — | $213.19K | — | Get Alert |
11/12/2019 | PM | MRKR | Q3 | — | -$1.30 | -$1.20 | 7.69% | — | — | $0.00 | — | Get Alert |
Marker Therapeutics (MRKR) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on November 9, 2023 for Q3.
The Actual EPS was $-0.34, which missed the estimate of $0.00.
The Actual Revenue was $257.6K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.